{"id":"W2980928034","doi":"10.1007/s00198-019-05146-9","title":"Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab","year":2019,"lang":"en","type":"article","venue":"Osteoporosis International","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":122,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Shionogi; UCB Pharma; Astellas Pharma; Gedeon Richter; Atara Biotherapeutics; Servier; Amgen; Pfizer; Teva Pharmaceutical Industries; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Denosumab; Bone mineral; Internal medicine; Placebo; Rheumatology; Bone Density Conservation Agents; Osteoporosis; Oncology; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004530898,0.0002861933,0.0006337703,0.0002180222,0.00008722686,0.00004276816,0.0002488647,0.000166906,0.003970745],"category_scores_gemma":[0.00009130788,0.0002011025,0.0002319142,0.0002117283,0.0001065987,0.0002260788,0.00008644016,0.0003812584,0.00009051833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002437447,"about_ca_system_score_gemma":0.0008490178,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001946036,"about_ca_topic_score_gemma":0.001281112,"domain_scores_codex":[0.9972587,0.00007211995,0.0005615901,0.0004903475,0.001121319,0.0004959146],"domain_scores_gemma":[0.9983473,0.0002075607,0.0002504134,0.0004912581,0.0003996597,0.0003038078],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03619429,0.002359437,0.8274153,0.0004430206,0.001250733,0.000524956,0.002850485,0.00002309166,0.09836175,0.000234324,0.01064097,0.01970162],"study_design_scores_gemma":[0.06239695,0.009995632,0.8253593,0.001168709,0.0001946517,0.001403762,0.002712712,0.001531471,0.0640137,0.00006358788,0.03017167,0.0009878731],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985814,0.0002925702,0.00001817577,0.001118366,0.0005146374,0.001083718,0.00007705179,0.00005237118,0.01102911],"genre_scores_gemma":[0.9810182,0.00008364252,0.001328801,0.0008279495,0.000166236,0.0000633423,0.0001720998,0.00005488703,0.01628481],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03434804,"threshold_uncertainty_score":0.9969398,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02734819200415372,"score_gpt":0.3253009263613552,"score_spread":0.2979527343572015,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}